+1-888-308-5802     
News Contact Us

Esoteric Testing Market on growth track| $35 bn by 2024

Author : Rahul Sankrityayan | Published Date : 2019-04-04 

The Esoteric Testing Market to exceed USD 35 billion by 2024; according to a new research report by Global Market Insights. Rising number of people suffering from rare diseases has escalated burden on healthcare systems to develop innovative test solutions, thereby fueling industry growth. Furthermore, sophistication of laboratory equipment leading to growing adoption of ground breaking technologies such as flow cytometry, mass spectrometry and real time-PCR will favor industry growth.

Increasing prevalence of chronic diseases and infectious diseases in developing countries such as China along with rising geriatric population, highly susceptible to suffer from chronic disorders will drive esoteric testing market over the forecast timeframe. Growing awareness about early disease detection along with rising demand for genomics and proteomic will positively impact market growth over the forecast period. However, lack of trained professionals and stringent regulations related with esoteric tests will restrain industry growth in future.

Request for a sample of this research report @ www.gminsights.com/request-sample/detail/1922

Personalized medicine has of late become clinical reality, a factor that has led to huge investments in proteomics and genomics industry. Increasing sophistication of the laboratory instruments along with growing implementation of advanced technologies like bioinformatics for complex disease treatment have upscaled the demand for esoteric testing market lately. Esoteric testing allows in-depth analysis of molecules that are not routinely performed in a clinical lab, subject to skilled medical technologists’ requirement and the expensive cost associated with these tests. Thus, many commercial laboratories outsource these complex tests to reference laboratories that are specialized in esoteric testing. However, with technology being profoundly penetrating the laboratory service space, many of the medium sized labs nowadays are performing these tests in-house. The massive surge in R&D investments is expected to expand esoteric testing industry periphery in the years ahead.
 
Globally, esoteric testing industry is highly regulatory driven, with mandatory roll outs by FDA and CLIA (Clinical Laboratory Improvement Amendments) that these clinical labs are required to comply with. In fact, stringent regulatory framework and uncomplimentary reimbursement scenario hinder the market penetration across some of the domains to some extent. While FDA regulates reagents, test kits, and other instruments that are widely deployed in esoteric laboratories for diagnostic purpose, highly complex testing laboratories require CLIA certification for performing these tests. The requirement of complying with all these regulatory approaches has resulted in an increased burden on small to medium sized laboratories. Amidst this backdrop, business collaboration is emerging as a top-notch strategy in the competitive landscape of esoteric testing market.
 
The strategic partnership of U.S. based metagenomics firm IDbyDNA with ARUP Laboratories is a testimony to the aforementioned aspect. Reportedly, with this collaboration, the firms aim to develop and commercialize advanced NGS (next generation sequencing) tests that are claimed to be more accurate and comprehensive. The partnership also outlines integration of laboratory medicine with data-driven analytics to exploit the benefits of precision medicine in infectious disease treatment. Market experts claim that similar kinds of collaboration will bring advanced genetic technology into clinical practice more rapidly, subsequently enhancing esoteric testing market outlook.  In this regard, it is important to note that market giants have been really optimistic and are betting big on Infectious disease and immunology, which in 2017, procured 28% of the overall esoteric testing industry landscape.
 
Oncology is yet another vital domain significantly influencing the esoteric testing market augmentation. This can be primarily credited to the increased detection of cancer at terminal stages which has led to a surge in demand for esoteric tests. Not to mention, the oncology application is also intensely characterized by the regulatory trends.  An instance validating the aforesaid is the sanction of Merck’s Keytruda drug by the U.S. FDA to be used for cancer treatment that is based on specific genetic defects. This is reportedly the first time any regulatory agency has approved cancer treatment that is solely based on a common bio maker, rather than on the location where the tumor is originated.
 
Regionally, U.S., China, Germany, U.K, Japan are poised to establish strong foothold in esoteric testing market space. The large patient pool suffering from infectious diseases, a significant development in health care infrastructure, rising demand for customized medication, and the growing prevalence of cancer are some of the factors driving the regional market trends. The U.S. procured 35% of the global market in 2017 and is anticipated to witness lucrative growth trends majorly on grounds of its upper hand in terms of medical advancements. China and Germany are anticipated to register CAGR of 12.5% and 8.5% respectively over 2018-2024.

Make an inquiry for purchasing this report @ www.gminsights.com/inquiry-before-buying/1922

Some of the key industry players operating in global esoteric testing market are Laboratory Corporation of America, Quest Diagnostics, Opko Health, and Arup Laboratories. Other players include Mayo Medical Laboratories, ACM Global Laboratories, American Esoteric Laboratories (AEL), Fulgent Genetics, Invitae, Myriad Genetics, Nordic Laboratories, Miraca Holdings, Genomic Health, BioMONTR.

About Author

Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for Fractovia, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in technical field as well as writing. He can be contacted at- [email protected] | https://twitter.com/sankritsays

Related News

Synthetic Food Market Projections, Industry Outlook, Business Outlook by 2024

Published Date: 2019-08-22         Author: Rahul Sankrityayan

Global Market Insights, Inc. has released a new research study on Synthetic Food Market analysis 2018-2023 inclusive of one or more factors covering regional opportunities, application landscape, product demand trends, and end-use portfolio of the industry over the forecast timeframe. The repor... Read More

Non-Alcoholic Beer Market Insights, Industry Projections, Regional Analysis by 2024

Published Date: 2019-08-22         Author: Rahul Sankrityayan

Global Market Insights, Inc. has announced the launch of Non-Alcoholic Beer Market, a comprehensive study enumerating the latest price trends and pivotal drivers rendering a positive impact on the industry landscape. Further, the report is inclusive of the competitive terrain of this vertical in add... Read More

Food Enzymes Market 2019 Analysis, Industry Strategy, Business Prospects by 2024

Published Date: 2019-08-22         Author: Rahul Sankrityayan

Global Market Insights, Inc. has added a new report on Food Enzymes Market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also ... Read More

© 2019 Fractovia. All Rights Reserved